Contact

Advisory

PACE has assembled advisory committees to provide strategic guidance to the programme and expertise to help select and support projects awarded funding.

Strategic Advisory Committee (SAC)

The SAC provides input and advocacy for the programme. Members are cross-sector experts in AMR. The committee provides advice and guidance to the JSB and JPMB on the strategic direction of the programme. Our SAC are not involved in the peer-review of applications for funding and do not provide recommendations on which research projects we should fund.

Professor Till Bachmann
Array
Professor Till Bachmann

Deputy Head of Infection Medicine & Personal Chair of Molecular Diagnostics and Infection, University of Edinburgh

Dr Ken Bradley
Array
Dr Ken Bradley

Global Head, Infectious Diseases Discovery Immunology, Roche Pharma Research and Early Development

Sue Charles
Array
Sue Charles

Independent Consultant, Charles Consultants; Member of the WHO Task Force of AMR Survivors

Nick Crabb
Array
Nick Crabb

CSO for Science, Evidence and Analytics, AMR Lead, NICE

Helen Dent
Array
Helen Dent

CEO, BIVDA

Dr Erin Duffy
Array
Dr Erin Duffy

Chief of Research & Development, CARB-X

Professor Sir Michael Ferguson
Array
Professor Sir Michael Ferguson

Regius Professor of Life Sciences, University of Dundee

Professor William Hope
Array
Professor William Hope

Dame Sally Davies Chair of AMR Research, University of Liverpool

Dr Seamus O'Brien
Array
Dr Seamus O'Brien

R&D Director, GARDP

Dr Deborah O’Neill
Array
Dr Deborah O’Neill

CEO, Novabiotics

Dr Maneesh Paul
Array
Dr Maneesh Paul

CEO, Microvioma

Dr Alexander Pym
Array
Dr Alexander Pym

Director of Infectious Disease, Wellcome

Florence Sejourne
Array
Florence Sejourne

CEO, Aurobac

Dr Mary de Silva
Array
Dr Mary de Silva

Deputy Chief Scientific Advisor, DHSC

Scientific Projects Advisory Group (SPAG)

SPAG members are experts in AMR research and development. They provide scientific review and assessment of research proposals as part of our funding call process and ongoing portfolio monitoring. They provide recommendations and advice to the JPMB. If necessary, more than one SPAG will be convened during the programme to complement the funding round at the time (e.g. therapeutics and diagnostics). Antibacterial Therapeutics SPAG. 

Dr Lloyd Czaplewski (Chair)
Array
Dr Lloyd Czaplewski (Chair)

Independent Consultant, Chemical Biology Ventures Ltd; CSO, Persica

Dr Nel Moore (Deputy Chair)
Array
Dr Nel Moore (Deputy Chair)

Independent Consultant, FW East Consulting

Professor Stephen Baker
Array
Professor Stephen Baker

Professor and Director of Research Global Health, University of Cambridge

Dr Benjamin Blasco
Array
Dr Benjamin Blasco

Senior Discovery Manager, GARDP

Dr Patricia Bradford
Array
Dr Patricia Bradford

Independent Consultant, Antimicrobial Development Specialists

Professor Karen Bush
Array
Professor Karen Bush

Professor of Practice Emerita, Indiana University Bloomington

Dr Jason Clark
Array
Dr Jason Clark

CSO, NexaBiome

Professor Martha Clokie
Array
Professor Martha Clokie

Professor of Microbiology, University of Leicester

Dr Aleksandar Danilovski
Array
Dr Aleksandar Danilovski

Independent Consultant; DALISCO d.o.o.

Dr Alice Erwin
Array
Dr Alice Erwin

Independent Consultant, Erwin Consulting LLC

Professor Ian Gilbert
Array
Professor Ian Gilbert

Professor of Drug Discovery, Drug Discovery Unit, University of Dundee

Dr Hideki Maki
Array
Dr Hideki Maki

Principal Investigator, Shionogi

Dr Ralph Minter
Array
Dr Ralph Minter

Senior VP of Research, Alchemab Therapeutics Ltd

Dr Claire Sadler
Array
Dr Claire Sadler

Independent Consultant, Sadler Scientific; Senior Toxicologist, Apconix

Dr Bala Subramanian
Array
Dr Bala Subramanian

CSO, Bugworks

Dr Peter Warn
Array
Dr Peter Warn

Independent Consultant, Magic Bullet Consulting

Dr Richard Vickers
Array
Dr Richard Vickers

Independent Consultant, Slade Consulting

AMR Community Representatives Committee (ACRC)

The voices of people with lived experience of AMR are integral to PACE. The ACRC reviews proposals from a patient and public perspective, providing insight, input and feedback to applications submitted as part of our funding calls and as part of ongoing portfolio delivery. In this way we are promoting a more person-centred approach to PACE funded research, resulting in better outcomes for all. 

We partnered with Vocal, a non-profit patient and public involvement and engagement organisation that specialises in connecting people to health research, to assemble the ACRC. Vocal hosts a network of people affected by AMR, as either patients or carers, and to date 13 members of this AMR community are involved in the ACRC. Learn more about Vocal and the AMR network.

 

 

Apply to join one of the PACE advisory committees

Apply Here